Genprex (GNPX) Net Equity Issued and Repurchased (2016 - 2026)

Genprex's Net Equity Issued and Repurchased history runs 10 years deep, the most recent figure standing at $13.4 million for Q1 2026.

• In Q1 2026, Net Equity Issued and Repurchased rose 121.58% year-over-year to $13.4 million; the TTM figure through Mar 2026 stood at $28.0 million (up 227.5% YoY), while the FY2025 annual figure was $21.5 million, up 79.32% from the prior year.
• Net Equity Issued and Repurchased for Q1 2026 stood at $13.4 million, up from $10.8 million in the prior quarter.
• The five-year high for Net Equity Issued and Repurchased was $13.4 million in Q1 2026, with the low at $4.0 in Q4 2023.
• The 5-year median for Net Equity Issued and Repurchased is $1.2 million (2024), against an average of $3.3 million.
• The sharpest annual moves came in 2023 and 2024: Net Equity Issued and Repurchased slumped 99.91% in 2023, then jumped 32150250.0% in 2024.
• Genprex's Net Equity Issued and Repurchased stood at $4672.0 in 2022, then plunged by 99.91% to $4.0 in 2023, then surged by 32150250.0% to $1.3 million in 2024, then jumped by 741.81% to $10.8 million in 2025, then advanced by 23.38% to $13.4 million in 2026.
• Business Quant data shows GNPX's Net Equity Issued and Repurchased at $13.4 million in Q1 2026, $10.8 million in Q4 2025, and $2.9 million in Q3 2025.